PortfoliosLab logoPortfoliosLab logo
ELMD vs. ZIVO
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ELMD vs. ZIVO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Electromed, Inc. (ELMD) and ZIVO Bioscience, Inc. (ZIVO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ELMD achieves a 27.34% return, which is significantly higher than ZIVO's -64.94% return. Both investments have delivered pretty close results over the past 10 years, with ELMD having a 23.42% annualized return and ZIVO not far ahead at 23.62%.


ELMD

1D
-1.62%
1M
37.69%
YTD
27.34%
6M
31.72%
1Y
76.99%
3Y*
46.60%
5Y*
27.60%
10Y*
23.42%

ZIVO

1D
0.00%
1M
-18.67%
YTD
-64.94%
6M
-67.89%
1Y
-82.28%
3Y*
-42.83%
5Y*
-36.44%
10Y*
23.62%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ELMD vs. ZIVO - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ELMD
Electromed, Inc.
27.34%-1.46%170.85%4.00%-19.31%32.52%13.41%69.94%-16.14%56.44%
ZIVO
ZIVO Bioscience, Inc.
-64.94%-59.53%1,691.67%-92.00%-12.89%1,813.33%-11.76%30.77%44.44%-5.26%

Correlation

The correlation between ELMD and ZIVO is -0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.05

Correlation (3Y)
Calculated over the trailing 3-year period

-0.03

Correlation (5Y)
Calculated over the trailing 5-year period

-0.02

Correlation (10Y)
Calculated over the trailing 10-year period

-0.00

Correlation (All Time)
Calculated using the full available price history since Sep 25, 2012

-0.02

Fundamentals

Market Cap

ELMD:

$320.66M

ZIVO:

$11.85M

EPS

ELMD:

$1.16

ZIVO:

-$2.58

PS Ratio

ELMD:

4.49

ZIVO:

98.33

Total Revenue (TTM)

ELMD:

$71.75M

ZIVO:

$119.03K

Gross Profit (TTM)

ELMD:

$56.28M

ZIVO:

$39.21K

EBITDA (TTM)

ELMD:

$14.10M

ZIVO:

-$9.86M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ELMD vs. ZIVO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ELMD
ELMD Risk / Return Rank: 8282
Overall Rank
ELMD Sharpe Ratio Rank: 8282
Sharpe Ratio Rank
ELMD Sortino Ratio Rank: 8181
Sortino Ratio Rank
ELMD Omega Ratio Rank: 8181
Omega Ratio Rank
ELMD Calmar Ratio Rank: 8585
Calmar Ratio Rank
ELMD Martin Ratio Rank: 8282
Martin Ratio Rank

ZIVO
ZIVO Risk / Return Rank: 1717
Overall Rank
ZIVO Sharpe Ratio Rank: 2222
Sharpe Ratio Rank
ZIVO Sortino Ratio Rank: 2626
Sortino Ratio Rank
ZIVO Omega Ratio Rank: 2626
Omega Ratio Rank
ZIVO Calmar Ratio Rank: 88
Calmar Ratio Rank
ZIVO Martin Ratio Rank: 44
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ELMD vs. ZIVO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Electromed, Inc. (ELMD) and ZIVO Bioscience, Inc. (ZIVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ELMDZIVODifference
Sharpe ratioReturn per unit of total volatility

+1.93

Sortino ratioReturn per unit of downside risk

+2.56

Omega ratioGain probability vs. loss probability

1.30

0.97

+0.33

Calmar ratioReturn relative to maximum drawdown

3.33

-0.88

+4.20

Martin ratioReturn relative to average drawdown

6.74

-1.63

+8.37

ELMD vs. ZIVO - Sharpe Ratio Comparison

The current ELMD Sharpe Ratio is 1.47, which is higher than the ZIVO Sharpe Ratio of -0.47. The chart below compares the historical Sharpe Ratios of ELMD and ZIVO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


ELMDZIVODifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.47

-0.47

+1.93

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.60

-0.26

+0.86

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.44

0.02

+0.42

Sharpe Ratio (All Time)

Calculated using the full available price history

0.22

0.01

+0.21

Drawdowns

ELMD vs. ZIVO - Drawdown Comparison

The maximum ELMD drawdown since its inception was -78.65%, smaller than the maximum ZIVO drawdown of -98.52%. Use the drawdown chart below to compare losses from any high point for ELMD and ZIVO.


Loading charts...

Drawdown Indicators


ELMDZIVODifference

Max Drawdown

Largest peak-to-trough decline

-78.65%

-98.52%

+19.87%

Max Drawdown (1Y)

Largest decline over 1 year

-23.27%

-93.85%

+70.58%

Max Drawdown (3Y)

Largest decline over 3 years

-48.86%

-97.16%

+48.30%

Max Drawdown (5Y)

Largest decline over 5 years

-48.86%

-98.52%

+49.66%

Max Drawdown (10Y)

Largest decline over 10 years

-55.84%

-98.52%

+42.68%

Current Drawdown

Current decline from peak

-5.62%

-90.67%

+85.05%

Average Drawdown

Average peak-to-trough decline

-33.79%

-63.75%

+29.96%

Ulcer Index

Depth and duration of drawdowns from previous peaks

11.49%

50.41%

-38.92%

Volatility

ELMD vs. ZIVO - Volatility Comparison

The current volatility for Electromed, Inc. (ELMD) is 26.28%, while ZIVO Bioscience, Inc. (ZIVO) has a volatility of 51.45%. This indicates that ELMD experiences smaller price fluctuations and is considered to be less risky than ZIVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ELMDZIVODifference

Volatility (1M)

Calculated over the trailing 1-month period

26.28%

51.45%

-25.17%

Volatility (6M)

Calculated over the trailing 6-month period

37.43%

144.20%

-106.77%

Volatility (1Y)

Calculated over the trailing 1-year period

52.93%

176.32%

-123.39%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

46.30%

139.16%

-92.86%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

52.99%

1,082.76%

-1,029.77%

Dividends

ELMD vs. ZIVO - Dividend Comparison

Neither ELMD nor ZIVO has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

ELMD vs. ZIVO - Financials Comparison

This section allows you to compare key financial metrics between Electromed, Inc. and ZIVO Bioscience, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00M10.00M15.00M20.00M20222023202420252026
18.58M
0
(ELMD) Total Revenue
(ZIVO) Total Revenue
Values in USD except per share items

Frequently Asked Questions


ELMD and ZIVO have a correlation of -0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ZIVO has higher volatility (51.45%) compared to ELMD (26.28%). In terms of maximum drawdown, ELMD dropped -78.65% vs ZIVO's -98.52%.

ELMD currently has the higher Sharpe Ratio (1.47 vs -0.47), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ELMD and ZIVO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer